Navigation Links
VetStem Biopharma Acquires 24 New Adipose Stem Cell Patents
Date:11/8/2016

VetStem Biopharma, Inc., announced the purchase of 24 issued US and foreign patents in the field of adipose stem cell therapy. These already issued patents cover a wide range of methods and uses of adipose stem cells including coverage for therapeutic use in neurologic, hepatic hematologic, and skeletal/smooth muscle diseases and injury. Key may be the coverage for spinal and CNS trauma and disease that are very common in humans and animals. These acquired patents provide substantial expansion of the VetStem portfolio, now in excess of 70 issued patents and cover veterinary and human use.

The VetStem patent strategy has been to assure freedom to operate and to license and own patents that provide for protection of our current commercial operations and protect the products in development. “For a developing company, patents are the core of value and allow us to protect our investment. We also out-license to compatible companies bringing complementary products and services to the human and animal markets” says CEO/Founder Dr. Robert Harman.    

The recent issuance of VetStem’s own adipose stem cell patent in the EU and US provides broad coverage of adipose stem cell extraction and therapeutic use in orthopedics in both human and veterinary markets. VetStem is already in discussions to license this patent to human stem cell companies, providing additional income streams to support further its FDA product development program.

VetStem anticipates its first FDA product approval, for canine osteoarthritis, in 2018 and is seeking global partners for broad commercialization. This product will be marketed in the US by Aratana Therapeutics, VetStem’s US licensee and commercial partner. Licenses are available for ex-US territories.

About VetStem Biopharma
VetStem Biopharma is a veterinarian-lead company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 14 years and 12,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global veterinary licenses to a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at http://www.prweb.com/releases/2016/11/prweb13827300.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma
2. VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples
3. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services.
4. West Coast Bird Dog Champion Wins US Bird Dog Association Western States National Flushing Champion with the help of Stem Cell Therapy by VetStem.
5. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma, Announces the Addition of Dr Ross Rich as the Director of Clinical Development
6. VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering
7. VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities.
8. VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center.
9. VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour
10. VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product
11. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to be a Guest Speaker at MSC 2015 Adult Stem Cell Therapy & Regenerative Medicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2019)... ... ... an albino, deaf Great Dane. His owners rescued him when he was four months old ... hearing impairment, he was always an active and playful pup. Frank bonded with his brother, ... the two grew, playtime became rougher and Frank ended up injuring his right rear leg. ...
(Date:4/18/2019)... WORCESTER, Mass. (PRWEB) , ... April 18, 2019 ... ... for fossil fuels, a research team that includes a chemical engineer at Worcester ... an exotic microorganism that may make it possible to manufacture isobutanol and other ...
(Date:4/16/2019)... ... April 16, 2019 , ... ... and technology, today announced that Bank South Pacific (BSP), the largest regionally owned ... The bank awarded Fulcrum a contract to deliver a fingerprint-based Know Your Customer ...
(Date:4/12/2019)... , ... April 12, 2019 , ... ... developments in neurotechnology and will educate about innovative tools and devices being used ... local listings for more information. , This segment of Advancements will focus on ...
Breaking Biology Technology:
(Date:5/23/2019)... ... May 23, 2019 , ... ... sales and service organizations, today announced its inclusion in DMG Consulting’s 2019-2020 Intelligent ... intelligent virtual agent (IVA) market share leader, based on number of customers, with ...
(Date:5/21/2019)... (PRWEB) , ... May 21, 2019 , ... Experiential tourism, ... rise in demand over the last several years. And according to a recent ... down anytime soon. In fact, more and more travelers are wanting their journeys ...
(Date:5/21/2019)... ... May 20, 2019 , ... Dr. David Greene , Founder and ... Stem Cell Therapy: Biotechnology to the Rescue, was produced by Award Winning filmmaker Dr. ... interviewed in regards to the safety of the procedures along with the potential for ...
Breaking Biology News(10 mins):